Elite Pharmaceuticals (ELTP) Cash & Equivalents (2010 - 2026)
Elite Pharmaceuticals' Cash & Equivalents came in at $39.42 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 77.6% from $22.2 million a year earlier and up 30.2% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Cash & Equivalents was $30.27 million, up 157.2% from FY2025.
- Cash & Equivalents carries a five-year compound annual growth rate of 56.8% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $11.77 million in FY2025 (+56.1%), $7.54 million in FY2024 (-8.6%), $8.24 million in FY2023 (-3.4%) and $8.54 million in FY2022 (+167.3%).
- The fiscal Q1 2027 figure represents the highest quarterly Cash & Equivalents in data going back to fiscal Q1 2011.
- Year-over-year, Cash & Equivalents has increased for eight consecutive quarters, with growth averaging 101.2% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q2 2023 (growth of 313.2%), and the weakest in fiscal Q3 2024 (a decline of 65.1%).
- Business Quant data shows ELTP's Cash & Equivalents at $30.27 million (Q4 2026), $21.56 million (Q3 2026) and $27.08 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,142.38 Bn | 1,110.97 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.12 Bn | 554.98 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 500.65 Bn | 473.76 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 355.26 Bn | 309.64 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 300.41 Bn | 264.40 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 263.79 Bn | 237.48 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 238.16 Bn | 193.56 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 170.34 Bn | 116.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Elite Pharmaceuticals | 264.57 Mn | 146.24 Mn | 13.51 Mn | 39.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.42 Mn |
| Mar 31, 2026 | 30.27 Mn |
| Dec 31, 2025 | 21.56 Mn |
| Sep 30, 2025 | 27.08 Mn |
| Jun 30, 2025 | 22.20 Mn |
| Mar 31, 2025 | 11.77 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 6.24 Mn |
| Sep 30, 2023 | 9.08 Mn |
| Jun 30, 2023 | 9.49 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 17.91 Mn |
| Sep 30, 2022 | 18.56 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 7.29 Mn |
| Sep 30, 2021 | 4.49 Mn |
| Jun 30, 2021 | 4.75 Mn |
API Access
Elite Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();